Skip to main content
Log in

MRSA admission screening not cost effective in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. isolation and decolonisation if possible, otherwise decolonisation plus contact precautions

  2. incremental cost-effectiveness ratio

Reference

  • Robotham J, et al. National One Week Audit of MRSA Admission Screening: Final results of the cost-effectiveness evaluation of MRSA screening strategies in English National Health Service (NHS) Hospitals. 23rd European Congress of Clinical Microbiology and Infectious Diseases : abstr. LB 2969, 27 Apr 2013.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

MRSA admission screening not cost effective in the UK. PharmacoEcon Outcomes News 679, 3 (2013). https://doi.org/10.1007/s40274-013-0421-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0421-7

Navigation